Predicting antimicrobial resistance for precision medicine
Cell Host & Microbe · 2026-07 · 34 (7) · 1186-1201
DOI: 10.1016/j.chom.2026.05.031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2026-07. Verfasst von Theresa Fink und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biological Physics, University of Cologne, 50931 Cologne, Germany. Hauptthemen laut MEDLINE: Precision Medicine, Anti-Bacterial Agents, Bacteria, Drug Resistance, Bacterial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, German Centre for Infection Research.
Abstract (Originalsprache)
Antibiotics are among medicine's greatest successes, but resistance evolution threatens their continued efficacy. Decades of research have deepened our understanding of the mechanisms and evolutionary dynamics of antimicrobial resistance. More recently, advances in machine learning (ML) and artificial intelligence (AI) show promise in predicting antimicrobial resistance in pathogens based on rapid whole-genome sequencing and other accessible data. In this perspective, we highlight advances in understanding the mechanisms and spread of antimicrobial resistance. We discuss how this knowledge, coupled with ML- and AI-based approaches, can inform the prediction of resistance and a precision-medicine strategy that targets pathogenic bacteria specifically, thereby limiting resistance evolution and collateral damage to the microbiome. These accurate predictions of bacterial vulnerabilities will enable the adaptation of classical antimicrobial treatments with adjuvants, as well as the use of novel, narrow-spectrum therapeutics. Implementing these strategies, while also identifying key challenges, will help bring this strategy into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biological Physics, University of Cologne, 50931 Cologne, Germany.
- Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hos…
- Institute for Biological Physics, University of Cologne, 50931 Cologne, Germany; Center for Data and Simulation Science, University of Cologne, 50931 Cologne, Germany. Electronic address: tbollenb@uni-koeln.de.
Förderung
- German Research Foundation
- German Centre for Infection Research
Zitieren
APA
Fink, T., Rybniker, J., & Bollenbach, T. (2026). Predicting antimicrobial resistance for precision medicine. Cell Host & Microbe, 34(7), 1186-1201. https://doi.org/10.1016/j.chom.2026.05.031
Vancouver
Fink T, Rybniker J, Bollenbach T. Predicting antimicrobial resistance for precision medicine. Cell Host & Microbe. 2026;34(7):1186-1201. doi:10.1016/j.chom.2026.05.031
BibTeX
@article{Fink2026,
author = {Fink, Theresa and Rybniker, Jan and Bollenbach, Tobias},
title = {Predicting antimicrobial resistance for precision medicine},
journal = {Cell Host & Microbe},
year = {2026},
volume = {34},
number = {7},
pages = {1186--1201},
doi = {10.1016/j.chom.2026.05.031}
}
EUVIMED